$3.05 0.08 (+2.69%)
2/13/2012 11:59 AM

Albany Molecular Research, Inc. (NASDAQ:AMRI)

CAPS Rating: 3 out of 5

The Company is a global chemistry-based drug discovery and development company focused on identifying and developing novel biologically active small molecules with applications in the drug market.

Featured Broker Partners


Advertisement